GlassScriptPhysician profile
Nabeel Hamoui
NPI 1497911762
$50,200.93
in general payments reported to CMS, 2019-2025
42 companies · $4,692 in 2025
The $4,692 reported for 2025 was more than what 90% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $614 · 2020: $13K · 2021: $5,347 · 2022: $22K · 2023: $2,740 · 2024: $2,222 · 2025: $4,692.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,782 · Consulting Fee: $1,873.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,781.61 |
| Consulting Fee | $1,872.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $36,576.39 | 2019-2023 | |
| Teleflex LLC | $2,958.40 | 2021-2025 | Urolift, Barrigel |
| Ethicon Endo-Surgery INC. | $1,872.50 | 2025 | |
| Procept Biorobotics Corporation | $1,711.97 | 2021-2025 | Aquabeam Robotic System, Aquabeam System |
| Boston Scientific Corporation | $1,303.32 | 2019-2025 | Ams 700, Ams 700 Cxr Rte Kit, Spaceoar Vue System - 10ml |
| Axonics, INC. | $923.58 | 2020-2024 | Axonics, Bulkamid |
| Medtronic, INC. | $785.90 | 2021-2025 | Interstim |
| Coloplast Corp | $467.83 | 2019-2025 | Altis |
| Astellas Pharma US INC | $430.94 | 2019-2024 | Veozah, Myrbetriq |
| Ethicon US, LLC | $324.48 | 2020-2025 | Echelon; Endopath, Dermabond |
| Endo Pharmaceuticals INC. | $280.64 | 2019-2023 | Xiaflex, Aveed |
| Dornier Medtech America, INC | $249.70 | 2025 | Dornier Medtech |
| United Medical Systems (De), INC. | $227.12 | 2024 | |
| Sumitomo Pharma America, INC. | $185.18 | 2023-2025 | Gemtesa |
| Abbvie INC. | $180.96 | 2022-2025 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $161.05 | 2022-2025 | Itind System |
| Neotract INC. | $158.36 | 2019-2020 | |
| Telix Pharmaceuticals | $139.07 | 2023-2025 | Illuccix |
| Laborie Medical Technologies Corp. | $125.51 | 2023-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Urovant Sciences INC | $120.83 | 2021-2022 | |
| Profound Medical Corp. | $118.10 | 2025 | Tulsa-Pro |
| Urogen Pharma, INC. | $106.82 | 2021-2025 | Jelmyto |
| Novartis Pharmaceuticals Corporation | $80.89 | 2019-2025 | |
| Accord Healthcare, INC. | $80.80 | 2022-2024 | |
| Rochester Medical Corporation | $79.20 | 2020 | |
| Janssen Biotech, INC. | $69.16 | 2019-2025 | Erleada |
| Verity Pharmaceuticals INC. | $60.09 | 2024-2025 | Trelstar |
| Tolmar, INC. | $53.00 | 2023-2025 | Eligard |
| Tolmar Pharmaceuticals, INC. | $50.30 | 2020-2022 | |
| Endocare, INC. | $44.12 | 2019 | |
| Allergan, INC. | $43.34 | 2019-2021 | |
| Clarus Therapeutics INC. | $32.68 | 2021 | |
| Antares Pharma, INC. | $32.45 | 2019 | |
| Civco Medical Instruments | $25.78 | 2024 | |
| 180 Medical, INC. | $24.23 | 2019 | |
| Metuchen Pharmaceuticals | $20.50 | 2020 | |
| Calyxo, INC. | $20.44 | 2025 | Cvac Aspiration System |
| Ferring Pharmaceuticals INC. | $19.02 | 2025 | Adstiladrin |
| Myovant Sciences INC. | $16.70 | 2021 | |
| Merck Sharp & Dohme LLC | $15.71 | 2021 | |
| Karl Storz Endoscopy-America | $13.02 | 2019 | |
| Pfizer INC. | $10.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nabeel Hamoui listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.